Bank of New York Mellon Corp - SALARIUS PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of SALARIUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$7,0000.0%35,2650.0%0.00%
Q2 2022$7,000
-50.0%
35,265
-0.7%
0.00%
Q1 2022$14,000
-22.2%
35,5060.0%0.00%
Q4 2021$18,000
-50.0%
35,5060.0%0.00%
Q3 2021$36,000
-5.3%
35,5060.0%0.00%
Q2 2021$38,000
-38.7%
35,506
-15.4%
0.00%
Q1 2021$62,000
+51.2%
41,979
-6.7%
0.00%
Q4 2020$41,000
+7.9%
45,0070.0%0.00%
Q3 2020$38,000
-35.6%
45,007
-0.4%
0.00%
Q2 2020$59,000
+90.3%
45,1870.0%0.00%
Q1 2020$31,00045,1870.00%
Other shareholders
SALARIUS PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Sio Capital Management, LLC 1,354,291$1,381,0000.44%
X-Square Capital, LLC 100,658$103,0000.05%
Maven Securities LTD 1,212,575$1,237,0000.04%
Kepos Capital LP 548,054$559,0000.04%
1900 WEALTH MANAGEMENT LLC 40,000$41,0000.00%
Laird Norton Wetherby Wealth Management, LLC 39,746$41,0000.00%
Virtu Financial LLC 29,708$30,0000.00%
Financial Advocates Investment Management 11,472$12,0000.00%
MEITAV INVESTMENT HOUSE LTD 52,000$53,0000.00%
NORTHERN TRUST CORP 67,227$68,0000.00%
View complete list of SALARIUS PHARMACEUTICALS INC shareholders